In a few studies with tumor tissue samples of DLBCL with survival analysis, high level expression or nuclear-weighted expression of Peli1 showed poor prognosis, while its prognostic effects were limited in multivariate analysis in R-CHOP-treated cohort 6, 8. Here, PELI1 is linked to diffuse large B-cell lymphoma.